Operating Cash Flow per Share: A measure of financial performance calculated as operating cash flow, expressed on a per share basis. Calculated as: Cash Flow from Operations / Weighted Average Shares Outstanding (Diluted)
Neurocrine Biosciences, Inc. (NBIX) had Operating Cash Flow per Share of $2.71 for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
$959.00M |
|
$144.40M |
|
$23.20M |
|
$935.80M |
|
$807.50M |
|
$151.50M |
|
$10.70M |
|
$162.20M |
|
$161.00M |
|
$144.40M |
|
$144.40M |
|
$144.40M |
|
$143.07M |
|
$151.50M |
|
$179.30M |
|
101.00M |
|
104.20M |
|
$1.43 |
|
$1.39 |
|
| Balance Sheet Financials | |
$1.64B |
|
$90.50M |
|
$3.72B |
|
$5.36B |
|
$874.50M |
|
-- |
|
$791.00M |
|
$1.67B |
|
$3.69B |
|
$967.00M |
|
$3.69B |
|
101.60M |
|
| Cash Flow Statement Financials | |
$282.20M |
|
$-641.60M |
|
$-22.70M |
|
$721.00M |
|
$338.90M |
|
$-382.10M |
|
$122.20M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.87 |
|
-- |
|
-- |
|
-- |
|
-- |
|
97.58% |
|
15.80% |
|
15.80% |
|
-- |
|
16.91% |
|
15.06% |
|
$265.30M |
|
-- |
|
-- |
|
-- |
|
0.18 |
|
0.22 |
|
1.08 |
|
83.24 |
|
3.91% |
|
14.93% |
|
2.69% |
|
3.91% |
|
$36.35 |
|
$2.55 |
|
|
Operating Cash Flow per Share |
$2.71 |